Startseite>>Signaling Pathways>> Neuroscience>> mAChR>>MK-7622 (M1 receptor modulator)

MK-7622 (M1 receptor modulator)

Katalog-Nr.GC30836

MK-7622 (M1-Rezeptor-Modulator) (M1-Rezeptor-Modulator) ist ein muskarinischer M1-Rezeptor-positiver allosterischer Modulator.

Products are for research use only. Not for human use. We do not sell to patients.

MK-7622 (M1 receptor modulator) Chemische Struktur

Cas No.: 1227923-29-6

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
60,00 $
Auf Lager
5mg
55,00 $
Auf Lager
10mg
88,00 $
Auf Lager
50mg
315,00 $
Auf Lager
100mg
540,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

MK-7622 is a muscarinic M1 receptor positive allosteric modulator.Target: M1 receptorMK-7622 is useful in the treatment of diseases in which the M1 receptor is involved, such as Alzheimer's disease, schizophrenia, pain or sleep disorders.

[1]. Kuduk Scott D, et al. Dihydrobenzoquinazolinone M1 receptor positive allosteric modulators. From PCT Int. Appl. (2012), WO 2012047702 A1 20120412. [2]. Kuduk Scott D, et al. Benzoquinazolinone derivatives as M1 receptor positive allosteric modulators and their preparation, pharmaceutical compositions and use in the treatment of diseases. From PCT Int. Appl. (2010), WO 2010059773 A1 20100527.

Bewertungen

Review for MK-7622 (M1 receptor modulator)

Average Rating: 5 ★★★★★ (Based on Reviews and 18 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for MK-7622 (M1 receptor modulator)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.